These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7504402)

  • 1. A novel Mediterranean "delta beta-thalassemia" determinant containing the delta (+) 27 and beta (0) 39 point mutations in cis.
    Oggiano L; Guiso L; Frogheri L; Loudianos G; Pistidda P; Rimini E; Pirastu M; Cao A; Longinotti M
    Am J Hematol; 1994 Jan; 45(1):81-4. PubMed ID: 7504402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal delta globin gene sequence in carrier of the silent-101 (C-T) beta-thalassemia mutation with normal HbA2 level.
    Ristaldi MS; Casula S; Porcu S; Cao A
    Am J Hematol; 2001 May; 67(1):58. PubMed ID: 11279661
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency of delta+ 27-thalassaemia in Sardinians.
    Guiso L; Frogheri L; Pistidda P; Angioni L; Dore F; Pardini S; Longinotti M
    Clin Lab Haematol; 1996 Dec; 18(4):241-4. PubMed ID: 9054695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece.
    Tzetis M; Traeger-Synodinos J; Kanavakis E; Metaxotou-Mavromati A; Kattamis C
    Hematol Pathol; 1994; 8(1-2):25-34. PubMed ID: 8034555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic phenotype of the mutations IVS1-n6 (T-->C), IVS1-n110 (G-->A), and CD39 (C-->T) in carriers of beta-thalassemia in Greece.
    Stefanis L; Kanavakis E; Traeger-Synodinos J; Tzetis M; Metaxotou-Mavromati A; Kattamis C
    Pediatr Hematol Oncol; 1994; 11(5):509-17. PubMed ID: 7530030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-thalassemia intermedia with exceptionally high hemoglobin A2: relationship to mutations in the beta-gene promoter.
    Coleman MB; Adams JG; Plonczynski MW; Harrell AH; Walker AM; Fairbanks V; Steinberg MH
    Am J Med Sci; 1992 Aug; 304(2):73-8. PubMed ID: 1380206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal delta-globin gene sequences in Sardinian nondeletional delta beta-thalassemia.
    Loudianos G; Moi P; Lavinha J; Galanello R; Cao A; Pirastu M
    Hemoglobin; 1992; 16(6):503-9. PubMed ID: 1487421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of a normal Hb A2 beta-thalassaemia determinant in a Sardinian family.
    Oggiano L; Pirastu M; Moi P; Longinotti M; Perseu L; Cao A
    Br J Haematol; 1987 Oct; 67(2):225-9. PubMed ID: 3676110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA2-Partinico or delta(A2)Pro-->Thr, a new genetic variation in the delta-globin gene in cis to the beta(+) thal IVS-I-110 G>A, and the heterogeneity of delta-globin alleles in double heterozygotes for beta- and delta-globin gene defects.
    Lacerra G; Scarano C; Musollino G; Testa R; Prezioso R; Caruso DG; Lagona LF; Medulla E; Friscia MG; Gaudiano C; Carestia C
    Ann Hematol; 2010 Feb; 89(2):127-34. PubMed ID: 19609526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
    Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
    Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Silent" β-thalassemia mutation (promoter nt-101 C > T) with increased hemoglobin A
    Aslan D
    Turk J Pediatr; 2016; 58(3):305-308. PubMed ID: 28266198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.
    Ottolenghi S; Camaschella C; Comi P; Giglioni B; Longinotti M; Oggiano L; Dore F; Sciarratta G; Ivaldi G; Saglio G
    Hum Genet; 1988 May; 79(1):13-7. PubMed ID: 2452784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian family.
    Galanello R; Podda A; Melis MA; Monne M; Cao A
    Prog Clin Biol Res; 1989; 316B():113-21. PubMed ID: 2482492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematological phenotypes in a family with triplicated alpha-globin gene, beta zero 39 and delta+27 thalassaemia mutations.
    Oggiano L; Rimini E; Frogheri L; Guiso L; Pistidda P; Longinotti M
    Clin Lab Haematol; 1992; 14(4):289-92. PubMed ID: 1478008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-thalassemia due to a mutation in an erythroid-specific binding protein sequence 3' to the delta-globin gene.
    Moi P; Loudianos G; Lavinha J; Murru S; Cossu P; Casu R; Oggiano L; Longinotti M; Cao A; Pirastu M
    Blood; 1992 Jan; 79(2):512-6. PubMed ID: 1309671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Corfu delta beta thalassaemia mutation in Greece: haematological phenotype and prevalence.
    Traeger-Synodinos J; Tzetis M; Kanavakis E; Metaxotou-Mavromati A; Kattamis C
    Br J Haematol; 1991 Oct; 79(2):302-5. PubMed ID: 1720325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Greek nondeletional hereditary persistence of fetal hemoglobin and beta-thalassemia compound heterozygotes.
    Papadakis MN; Patrinos GP; Tsaftaridis P; Loutradi-Anagnostou A
    J Mol Med (Berl); 2002 Apr; 80(4):243-7. PubMed ID: 11976733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate reduction of beta-globin gene transcript by a novel mutation in the 5' untranslated region: a study of its interaction with other genotypes in two families.
    Ho PJ; Rochette J; Fisher CA; Wonke B; Jarvis MK; Yardumian A; Thein SL
    Blood; 1996 Feb; 87(3):1170-8. PubMed ID: 8562944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.
    Amato A; Cappabianca MP; Perri M; Zaghis I; Grisanti P; Ponzini D; Di Biagio P
    Int J Lab Hematol; 2014 Feb; 36(1):13-9. PubMed ID: 23621512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.